Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine for minimally invasive direct coronary artery bypass surgery
2022-003684-14Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Intrathecal morphine with Intrathecal placebo (2 arms). Primary endpoint: Quality of recovery-40 (QoR-40) at 24 hours after extubation. Started Jan 2023; status: completed.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2022-003684-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003684-14.